Schwartz et al., in their study on the GATA-3 expression in different salivary gland tumors, noted that GATA-3 staining was observed in most of the salivary gland tumor types and is weakly positive in both acini and ducts of background benign salivary gland tissue, but diffuse immunolabeling was consistently seen in high-grade salivary duct carcinoma and secretory carcinoma, that is, the two tumor types that most closely resemble breast neoplasia [12]. Here, GATA3 is linked to neoplasm.